Form 4 for GOSS Gossamer Bio, Inc.
Accepted 2024-06-24 00:00:00 ET · period of report 2024-06-21 · accession 0001728117-24-000076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-06-24 | 2024-06-21 | GOSS | Hasnain Faheem | Pres, CEO, Dir | P - Purchase | $0.67 | +372.0K | 5.41M | +7% | +$249.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-21 | P | A | 372,000 | $0.67 | 5,408,073 | I By family trust | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $0.6079 to $0.7217 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |